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Food allergy (FA) affects 2%–10% of US children and is a growing clinical and public health
problem. Here we conduct the first genome-wide association study of well-defined FA, including
specific subtypes (peanut, milk and egg) in 2,759 US participants (1,315 children and 1,444
parents) from the Chicago Food Allergy Study, and identify peanut allergy (PA)-specific loci in the
HLA-DR and -DQ gene region at 6p21.32, tagged by rs7192 (P¼ 5.5 10 8) and rs9275596
(P¼6.8 10 10), in 2,197 participants of European ancestry. We replicate these associations in
an independent sample of European ancestry. These associations are further supported by meta-
analyses across the discovery and replication samples. Both single-nucleotide polymorphisms
(SNPs) are associated with differential DNA methylation levels at multiple CpG sites
(Po5 10 8), and differential DNA methylation of the HLA-DQB1 and HLA-DRB1 genes partially
mediate the identified SNP–PA associations. This study suggests that the HLA-DR and -DQ gene
region probably poses significant genetic risk for PA.
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F
ood allergy (FA), defined as immunoglobulin E (IgE)-
mediated clinical reactivity to specific food proteins, affects
2%–10% of children in the United States1,2. Over the past 20
years, FA has grown from a relatively uncommon to a major
clinical and public health problem worldwide, due to its
increasing prevalence, potential fatality and enormous medical
and economic impact3–5. FA accounts for more than $20 billion
in overall annual healthcare costs in the United States5. To date,
there is no safe and effective prevention or treatment for FA,
which is approved by the Food and Drug Administration for use
in clinical practice, except for emergency management of allergic
reactions induced by accidental exposure. Strict food avoidance is
the only effective strategy to prevent future allergic reactions
among FA patients; however, this is exceedingly difficult, as
peanut, egg and cow’s milk (the three most common food
allergens in the United States3) are ubiquitous in processed foods.
Indeed, a growing body of literature has shown that FA
significantly diminishes quality of life among affected patients
and their caregivers3,6,7, who live in constant fear of accidental
ingestion and potentially life-threatening reactions.
A major obstacle to effective prevention and treatment of FA is
our limited understanding of its causes and underlying biological
mechanisms. Although available data support a role for genetic
factors in FA based on familial aggregation studies8,9 and
heritability estimates (ranging from 15% to 82%)8,10, few
specific genes have been conclusively associated with FA,
leaving its heritability largely unexplained. To date, all
published genetic studies of FA have used a candidate gene
approach, and have predominantly focused on peanut allergy
(PA), a common type of FA that accounts for a disproportionate
number of fatal and near-fatal food-induced episodes of
anaphylaxis. Although multiple candidate genes have been
reported for PA, few are considered established due to small
sample sizes11–17, lack of adjustment for multiple comparisons12–
14,16–18 and a high failure rate in genotyping calls18. To our
knowledge, loss-of-function mutations in the gene encoding
filaggrin (FLG) are among the few genetic risk factors replicated
for PA in multiple populations19–21. For other allergic diseases,
genome-wide association studies (GWASs) have shown promise
in recent years in dissecting the genetic basis of asthma22–24 and
atopic dermatitis25–27. Two recent GWASs have examined
allergen sensitization28 and self-reported environmental
allergy29. These previous GWASs did not specifically examine
FA, but did reveal substantial differences in genetic effects across
various allergies29. Clinical FA is distinct from sensitization to
foods or aeroallergens: a sensitized child may or may not manifest
clinical signs or symptoms of FA, underscoring the need to
explore genetic variants specifically associated with clinical FA (a
growing clinical and public health challenge).
Epigenetic mechanisms by which genetic variants affect FA are
largely unexplored. DNA methylation (DNAm), a type of
epigenetic mark, regulates gene expression. There is growing
evidence that genetic variants can affect DNAm30,31, and that
DNAm may mediate genetic susceptibility to autoimmune
disease32. To date, no published study on FA has
simultaneously considered genome-wide genetic and epigenetic
factors, nor have they assessed whether DNAm could mediate
genetic susceptibility to FA.
To our knowledge, this is the first GWAS of well-defined FA in
a US cohort of children and their biological parents. This study
comprises three stages. In stage I, we use the modified quasi-
likelihood score (MQLS) test33,34 to detect genetic associations
with any FA (including nine foods as follows: peanut, egg white,
cow’s milk, soy, wheat, walnut, fish, shellfish and sesame seed)
and the three most common types of FA (peanut, egg white and
cow’s milk). We identify PA-specific loci in the human leukocyte
antigen (HLA)-DQ and -DR region at 6p21.32, tagged by rs7192
and rs9275596, respectively. In stage II, we perform a replication
study of identified single-nucleotide polymorphisms (SNPs) from
stage I in an independent sample from the same cohort, and
confirm that both rs7192 and rs9275596 are significantly
associated with PA. In stage III, we examine relationships
between the two PA-associated SNPs and DNAm, between
genotype-dependent DNAm and PA, and also whether DNAm
mediates identified SNP–PA associations. We find that both
SNPs are significantly associated with differential DNAm at
multiple CpG sites and differential DNAm of the HLA-DQB1
and HLA-DRB1 genes partially mediate the identified SNP–PA
association. The population attributable risk (PAR) is 21%
and 19%, respectively, for rs7192 and rs9275596. Taken
together, this study indicates the possibility that the HLA-DR
and -DQ gene region likely poses the single greatest genetic risk
for PA.
Results
Phenotype definition and population characteristics. This study
includes three stages as shown in Fig. 1. Both discovery and
replication samples were from the Chicago Food Allergy Study
and were collected under a standard study protocol, as described
in the Methods. Main phenotypes of interest included ‘any FA’
and the three most common types of FA: PA, egg allergy and milk
allergy. As described in our previous report35, we applied
stringent clinical criteria to define specific types of FA as
follows: (1) a convincing history of clinical allergic reaction on
ingestion of a specified food and (2) evidence of sensitization to
the same food, defined as having a detectable food-specific IgE
(Z0.10 kU l 1) and/or a positive skin prick test (SPT) with mean
Genome-wide genotyping and data cleaning
65 Samples excluded
222,182 SNPs excluded
MQLS analyses
Samples: 2,694 subjects (1, 283 children and 1,411 parents)
SNPs: 789,677 genotyped SNPs, 5,670,165 imputed SNPs
Outcomes: any food allergy
peanut allergy
egg allergy
milk allergy
European ancestry Non-European ancestry
Non-European ancestry
Samples: 497 subjects
234 children and 263 parents
82 Children
24 PA cases and 58 controls
2 Top SNPs
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replication
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methylation
mediation
Samples: 2,197 subjects
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62 PA cases and 69 controls
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SNP-methylation associations
Methylation–PA associations
Causal inference tests
Samples: 73 PA cases and 67 controls
DMPs: 72 genotype-dependent DMPs
Samples: 73 PA cases and 67 controls
DMPs: 4 top DMPs associated with both SNPs and PA
Samples: 218 children of European ancestry
Platform: Infinium HumanMethylation450 BeadChips
1,049 children and 1,148 parents
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discovery
Samples: 2,759 subjects (1,315 children and 1,444 parents)
Platform: Illumina HumanOmni 1-Quad Beadchip
Figure 1 | Study design and work flow diagram for the GWAS of FA.
DMP, differentially methylated position; MQLS, modified quasi-likelihood
score analyses; PA, peanut allergy; SNP, single-nucleotide polymorphism.
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weal diameter (MWD)Z3mm to this specified food (see
Methods). Accordingly, we defined specific types of FA to nine
common foods (accounting for 495% of all FAs in the
population) and defined a child as having any FA if she/he was
allergic to any of the nine foods. In the genetic association
analyses, we also performed sensitivity analysis using other
cutoffs for food-specific IgE and SPT to define FA, for example,
food-specific IgEZ0.35 kU l 1, SPT MWDZ5mm (ref. 36)
or either food-specific IgE or SPT MWD Z95% positive
predictive value (PPV).
GWAS to identify susceptibility loci for FA (Stage I). A total of
2,759 samples (1,315 children and 1,444 biological parents) from
the Chicago Food Allergy Study9,35 were genotyped using the
Illumina HumanOmni1-Quad BeadChip. We performed vigorous
quality control and thorough data cleaning as detailed in
Methods. The final sample size for gene discovery (Stage I)
included 2,197 individuals of European ancestry (671 FA-affected
children) and 497 individuals of non-European ancestry (155 FA-
affected children). Each individual’s genetic ancestry was
estimated by principal component analysis (PCA)37 by using
the 1000 Genomes Project as a reference. The demographic and
clinical characteristics of all study participants are provided in
Supplementary Table 1.
The Stage I analyses included primarily family-based samples,
with a small number of case–control samples. The MQLS test33,34
was applied to test for genetic associations with FA due to its
capacity to maximally use available information contained in the
complex family data set (see Methods). The MQLS test allows for
two types of controls: unaffected controls and controls of
uncertain phenotypes. In this study, the children who did not
meet FA case or control definitions and all parents were coded as
controls of uncertain phenotypes (see Methods). We also
performed sensitivity tests in different ways to incorporate
controls of uncertain phenotypes.
To minimize population stratification, we first performed the
MQLS test in 2,197 individuals of European ancestry, and then
examined whether the identified genome-wide significant asso-
ciation signals were also present in 497 individuals of non-
European ancestry. The quantile–quantile plots for association
analyses in 2,197 individuals of European ancestry indicated
no inflation of the MQLS test due to cryptic population structure
or unaccounted relatedness among individuals (Fig. 2 and
Supplementary Fig. 1).
We performed the MQLS test to examine genome-wide
associations for any FA in 2,197 individuals of European ancestry,
including 671 FA cases, 144 non-allergic non-sensitized normal
controls and 1,382 controls of uncertain phenotypes (234
children and 1,148 parents). Under an additive model for the
minor allele of each SNP, we found that no SNP reached genome-
wide significance (Po5 10 8) or suggestive (Po1 10 7)
threshold (Table 1). Removing the 234 children with uncertain
phenotypes from these analyses did not substantially change the
results.
We further examined genome-wide associations for PA, egg
allergy and milk allergy among 2,197 individuals of European
ancestry. In 316 PA cases, 144 non-allergic non-sensitized
controls and 1,737 controls of uncertain phenotypes (589
children and 1,148 parents), the MQLS test identified genome-
wide significant associations for 40 SNPs spanning the HLA class
II DQ genes at the 6p21.32 region (Fig. 2 and Supplementary
Table 2). An intergenic SNP, rs9275596, between the HLA-DQB1
and HLA-DQA2 genes, showed the most significant association
with PA (P¼ 6.8 10 10; Fig. 3 and Supplementary Table 2).
The other 39 SNPs were predominantly in moderate-to-strong
linkage disequilibrium (LD) with rs9275596 (Fig. 3 and
Supplementary Table 2), and their associations with PA were
no longer significant when conditioning on rs9275596 (all
P40.001), suggesting that this group of SNPs represents a single
significant genetic signal for PA. At4200 kb upstream from this
significant signal, eight SNPs located within or clustered around
the HLA-DRA gene were in strong LD with each other (r2¼ 1)
and showed suggestive associations with PA (Po1 10 7;
Fig. 3). Among these identified SNPs, rs7192 (P¼ 5.5 10 8)
was the only coding SNP that leads to a Leu242Val change
in the HLA-DRA gene product. The odds ratio (OR) and
95% confidence intervals (CIs) were the same for one copy
of the rs7192-T allele and one copy of the rs9275596-C allele: 1.7
(95% CI: 1.4–2.1), as estimated by a generalized estimating
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Figure 2 | Quantile–quantile (Q–Q) and Manhattan plots for genome-
wide associations of PA in 2,197 discovery samples of European ancestry.
(a) Q–Q plots for all of the genotyped and/or imputed SNPs and SNPs
outside of the HLA-DQ and -DR region. (b) Manhattan plots for the
genotyped SNPs alone (upper panel) and for the genotyped plus imputed
SNPs. SNPs above the dashed line reached genome-wide significance at
5 10 8, based on the MQLS test.
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equation (GEE) regression model (Table 2). The association
between rs9275596 and PA was significantly reduced (OR¼ 1.4,
95% CI¼ 1.1–1.8, P¼ 0.01) when conditioned on rs7192,
suggesting that SNP rs9275596 and rs7192 may represent a
single risk factor for PA.
We performed a sensitivity test to examine whether the
identified genetic associations for PA varied by IgE or SPT
cutoffs. As shown in Table 3, the estimated ORs for either rs7192
or rs9275596 remained similar when more stringent IgE or SPT
cutoffs were applied. We then tested associations for rs7192 and
rs9275596 with PA, in 497 individuals of non-European ancestry.
No significant associations were detected (Table 2). These results
were unchanged when a quantitative version of MQLS analyses
was applied to adjust for ancestry based on the first three
principal components (PCs) from the genome-wide SNP
genotypes.
The MQLS test for egg allergy and milk allergy did not identify
any genome-wide significant or suggestive SNPs in the 2,197
individuals of European ancestry, and the two PA-associated
SNPs (rs7192 and rs9275596) showed no evidence of association
with either egg or milk allergy (Table 1). Neither rs7192 nor
rs9275596 showed associations with other allergic phenotypes in
2,197 individuals of European ancestry (Supplementary Table 3).
SNP imputation was also conducted in this study. With the
latest versions of SHAPEIT38 and IMPUTE2 (ref. 39), a total of
6,459,842 genotyped and/or imputed SNPs passed post-
imputation quality control steps (see Methods) and were then
tested for their associations with each outcome (any FA, PA, egg
allergy and milk allergy) among 2,197 individuals of European
ancestry. The MQLS test for PA revealed a single genome-wide
significant peak at 6p21.32, the same region identified in our
original analysis of genotyped SNPs alone (Fig. 2), but the peak
now included an additional 99 imputed SNPs (Supplementary
Table 2). Imputed SNP rs33980016 (an insertion/deletion SNP in
the intronic region of the HLA-DQB1 gene) showed the most
significant association with PA (P¼ 3.2 10 11; Fig. 3); it was in
moderate LD (r2¼ 0.54) with genotyped SNP rs9275596. When
conditioned on the genotyped SNP (rs9275596 or rs7192), the
association between rs33980016 and PA was largely reduced
(P40.001), suggesting that these imputed and genotyped SNPs
may represent one single genetic region. No genome-wide
significant or suggestive associations were identified for any FA
and egg allergy (Supplementary Fig. 1). Four imputed SNPs on
chromosome 3, located between the C3orf67 and LOC339902
genes, showed suggestive associations (Po5 10 7) with milk
allergy. However, this suggestive peak appears to be driven by
imputed SNPs, because there is no such association based on
genotyped SNPs in this region (Supplementary Fig. 1).
As no genome-wide significant associations were found for any
FA, egg allergy or milk allergy, we narrowed the scope of our
replication and DNAm mediation analyses to focus on PA.
Replication and meta analyses (Stage II). We performed a
replication study for two genotyped PA-associated SNPs,
rs9275596 (the most significant genotyped SNP for PA) and
rs7192 (a potential functional SNP), in an independent sample
(86 PA cases and 127 controls) from the same Chicago Food
Table 1 | The top loci associated with FA and the three most common types of FA in 2,197 discovery samples of European
ancestry.
SNP CHR Position Nearest gene Allele* MAFw P for SNP–phenotype associationz
FA PA Egg allergy Milk allergy
The five top loci for FA
rs12121623 1 54931396 SSBP3|ACOT11 G/T 0.13 3.1 10 7 0.024 0.046 0.053
rs1318710 4 101436201 EMCN A/G 0.10 2.6 106 0.002 0.020 0.207
rs777717 2 195954734 LOC645314|SLC39A10 C/T 0.08 4.7 10 6 0.008 0.057 0.214
rs10994607 10 62760742 RHOBTB1 C/T 0.04 7.1 10 6 0.250 0.028 4.6 10 5
rs6942407 7 86861313 LOC100289677|TP53TG1 G/A 0.21 8.2 106 7.6 104 0.016 0.003
The five top loci for PA
rs9275596 6 32681631 HLA-DQB1|HLA-DQA2 T/C 0.35 0.006 6.8 10 10 0.509 0.247
rs7192 6 32411646 HLA-DRA G/T 0.39 0.175 5.5 108 0.293 0.468
rs862942 14 26492233 STXBP6|NOVA1 T/C 0.07 2.7 104 3.0 10 6 0.169 0.026
rs4584173 8 135336557 LOC100129104|ZFAT T/C 0.40 0.031 3.6 10 6 0.168 0.386
rs10878354 12 66384885 HMGA2|LLPH G/A 0.23 0.031 5.1 106 0.603 0.451
The five top loci for egg allergy
rs7717393 5 155753914 SGCD C/G 0.07 0.067 0.627 1.4 10 6 2.7 104
rs5961136 23 54802520 ITIH5L T/G 0.39 0.251 0.067 2.4 106 0.900
rs250585 16 23401076 COG7 G/A 0.17 0.003 0.101 3.8 106 0.021
rs16823014 2 169817713 ABCB11 G/A 0.05 0.352 0.563 4.4 10 6 0.052
rs6498482 16 13987719 LOC729993|ERCC4 T/C 0.39 0.022 0.158 4.8 106 0.006
The five top loci for milk allergy
rs9898058 17 47818821 FAM117A C/T 0.15 7.7 10 5 0.014 0.016 1.1 106
rs17032597 2 67055115 LOC100289292|ETAA1 C/A 0.29 0.003 0.568 0.074 1.6 10 6
rs78405116 11 1892562 LSP1 G/T 0.03 0.015 0.423 0.775 1.7 10 6
rs10994613 10 62780127 RHOBTB1|TMEM26 G/A 0.03 1.6 10 5 0.997 0.036 4.8 106
rs7833294 8 58008281 IMPAD1|LOC286177 C/T 0.02 0.281 0.504 0.066 7.3 106
CHR, chromosome; FA, food allergy; MAF, minor allele frequency; MQLS, modified quasi-likelihood score; PA, peanut allergy; SNP, single-nucleotide polymorphism.
Only the genotyped SNP with the minimum P-value based on the MQLS test is shown for each gene.
*Major/minor allele.
wThe MAF was calculated using the genotyping data from parents of European ancestry.
zP-value was generated using the MQLS test in the 2,197 discovery samples.
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Allergy cohort. Sample selection criteria and data cleaning pro-
cedures are provided in Methods. The demographic character-
istics of the replication sample are presented in Supplementary
Table 4. There were 131 children (62 PA cases and 69 controls) of
European ancestry and 82 of non-European ancestry (24 PA cases
and 58 controls) based on PCA analysis. Using GEE models to
account for correlations among the 23 sibling pairs and to
adjust for age and gender, we found that both rs7192 (OR¼ 1.8,
95% CI¼ 1.2–2.7, P¼ 0.005) and rs9275596 (OR¼ 1.7, 95%
CI¼ 1.1–2.6, P¼ 0. 022) were significantly associated with PA
after Bonferroni correction (Po0.025 for two SNP tests) in
children of European ancestry, and that both SNPs had a similar
effect size as seen in the Stage I GWAS results (Table 2). No such
associations were detected in children of non-European ancestry
(Table 2).
Using allele frequencies reported in the HapMap Utah
Residents with Northern and Western European Ancestry
(CEU) and ORs derived from the replication sample of European
ancestry (to avoid ‘winner’s curse’ bias), we estimated the PAR,
which was 21% for rs7192 and 19% for rs9275596.
DNAm mediation (Stage III). In 218 unrelated children of
European ancestry (including 73 PA cases, 67 non-PA controls
and 78 children with uncertain PA phenotype), we tested asso-
ciations between the top genotyped SNPs (rs7192 and rs9275596)
and whole-blood DNAm levels at genome-wide CpG sites derived
from the Infinium HumanMethylation450 BeadChip. When
adjusting for age, gender and estimated cell composition (see
Methods), we identified 72 differentially methylated positions
(DMPs, Po5 10 8): 69 located at chromosome 6p21.32
(Fig. 4a), 1 at 7q22 (cg03324851 in the GNB2 gene), 1 at 12q24.33
(cg01256320 in the FBRSL1 gene) and 1 at 17q25.1 (cg12311094
in the C17orf77 gene). Of these 72 DMPs, 29 were significantly
associated with rs7192 and rs9275596 (the top PA-associated
genotyped SNPs), 17 were significantly associated with rs7192
and the remaining 26 DMPs were significantly associated with
rs9275596.
The 72 identified genotype-dependent DMPs were then tested
for their associations with PA in 73 PA cases and in 67 non-PA
controls. The estimated proportion of CD4T cells in whole blood
was slightly lower in PA cases than in controls (P¼ 0.02). With
the adjustment for age, gender and estimated cell composition, a
total of 18 DMPs, located in the c6orf10 (N¼ 7), HLA-DRB5
(N¼ 2), HLA-DRB1 (N¼ 8) and HLA-DQB1 (N¼ 1) genes,
respectively, were significantly associated with the risk of PA after
Bonferroni correction (Po0.0005) and showed a Z5% adjusted
methylation level difference between PA cases and controls
(Fig. 4a).
For each of the four identified genes (c6orf10, HLA-DRB5,
HLA-DRB1 and HLA-DQB1), the top DMP, which was (1)
significantly associated with both rs7192 and rs9275596
(Po5 10 8), and (2) yielded the smallest P-value in associa-
tion tests with PA, was further tested for its role in mediating the
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Figure 3 | Locus-specific plot of PA-associated loci reaching genome-
wide significance. Each dot represents the  log10 (P-value) for one
genotyped or imputed SNP based on the MQLS test in 2,197 discovery
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1000 Genomes Project data are shown as blue lines and the genomic
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Table 2 | The estimated effect sizes of the two top SNPs on risk of PA in the discovery and replication samples.
SNP Allele* Discovery Replication Pmeta
z
Casew Controlw Uncertainw,z OR (95% CI)y PMQLS|| Casew Controlw OR (95% CI)y PGEEy
Subjects with European ancestry
N¼ 316 N¼ 144 N¼ 1,737z N¼ 62 N¼69
rs7192 G/T 0.49 0.42 0.40 1.7 (1.4–2.1) 5.5 10 8 0.50 0.31 1.8 (1.2–2.7) 0.005 2.7 10 9
rs9275596 T/C 0.46 0.37 0.35 1.7 (1.4–2.1) 6.8 10 10 0.44 0.31 1.7 (1.1–2.6) 0.022 6.3 10 11
Subjects with non-European ancestry
N¼ 80 N¼ 15 N¼402# N¼ 24 N¼ 58
rs7192 G/T 0.43 0.46 0.36 1.2 (0.8–1.8) 0.198 0.42 0.36 1.4 (0.7–3.1) 0.375 0.147
rs9275596 T/C 0.34 0.41 0.30 1.2 (0.8–1.8) 0.327 0.25 0.40 0.6 (0.2–1.3) 0.176 0.420
CI, confidence interval; GEE, generalized estimating equation; MQLS, modified quasi-likelihood score; OR, odds ratio; PA, peanut allergy; SNP, single-nucleotide polymorphism.
*Major/minor allele. The major allele is the reference allele and the minor allele is the effective allele.
wMinor allele frequency is shown in each group.
zControls of uncertain phenotype, which included 1,148 parents and 589 children.
yThe GEE model was applied to estimate the effect size of each SNP (additive genetic model) on the risk of PA in children with and without PA, with adjustment for age and gender. For analyses in non-
European subjects, besides age and gender, we also included as covariates the first three principal components from the genome-wide SNP genotypes, to control for potential population stratification.
||P-value from the MQLS analyses in the 2,197 discovery samples.
zMeta-analysis was performed based on the Stouffer’s weighted z-score method to combine association results from the MQLS analyses in the discovery sample and from the GEE analyses in the
replication sample.
#Controls of uncertain phenotype, which included 263 parents and 139 children.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7304 ARTICLE
NATURE COMMUNICATIONS | 6:6304 | DOI: 10.1038/ncomms7304 |www.nature.com/naturecommunications 5
& 2015 Macmillan Publishers Limited. All rights reserved.
SNP–PA association via a causal inference test (CIT) (Table 4).
Briefly, to be a qualified mediator, this CIT must meet the
following criteria32,40: (i) genotype and PA are associated; (ii)
genotype is associated with DMP independent of PA; (iii) DMP is
associated with PA independent of genotype; and (iv) genotype is
not independently associated with PA after adjusting for DMP.
We found cg15982117 in the HLA-DRB1 gene and cg18024368 in
the HLA-DQB1 gene significantly mediated the effects of rs7192
and rs9275596 on PA (Table 4, all PCITo0.005) after Bonferroni
correction for four different DMPs and two different SNPs. As an
example, Fig. 4b shows that DMP cg18024368 in the HLA-DQB1
gene was significantly hypomethylated in children carrying the T
risk allele at rs7192 (P¼ 2.7 10 10; Fig. 4b, left panel) and also
in PA cases (N¼ 73) compared with non-PA controls (N¼ 67,
P¼ 2.4 10 6; Fig. 4b, middle panel). The estimated OR for the
rs7192–PA association was substantially reduced after adjusting
Table 3 | Associations of the two top SNPs with PA based on various definitions in 2,197 discovery samples of European ancestry.
PA definitions Cases rs7192* rs9275596w
ORz 95% CIz PGEEz PMQLSy ORz 95% CIz PGEEz PMQLSy
CR, plus psIgE Z0.1 kU l 1 or SPT Z3mm 316 1.7 1.4–2.1 1.7 10 7 5.5 10 8 1.7 1.4–2.1 9.6 108 6.8 10 10
CR in 2 h, plus psIgE Z0.1 kU l 1 or SPT Z3mm 286 1.8 1.4–2.2 1.5 10 7 6.7 10 8 1.8 1.4–2.2 1.8 10 7 1.9 10 9
CR in 2 h, plus psIgE Z0.35 kU l 1 or SPT Z3mm 278 1.8 1.4–2.2 2.0 10 7 1.0 10 7 1.8 1.4–2.2 1.8 10 7 2.5 109
CR in 2 h, plus psIgE Z0.35 kU l 1 or SPT Z5mm 276 1.7 1.4–2.2 4.2 10 7 3.6 10 7 1.7 1.4–2.2 3.0 10 7 6.7 10 9
CR in 2 h, plus psIgE Z15 kU l 1 or SPT Z8mm 216 1.8 1.4–2.3 7.5 10 7 1.4 106 1.8 1.4–2.3 7.0 10 7 8.9 108
CR in 2 h, plus psIgE Z57 kU l 1 or SPT Z8mm 187 1.8 1.4–2.3 4.2 106 2.3 10 5 1.8 1.4–2.2 9.2 10 6 4.2 10 6
CI, confidence interval; CR, clinical allergic reaction to peanut ingestion; GEE, generalized estimating equation; MQLS, modified quasi-likelihood score; OR, odds ratio; PA, peanut allergy; psIgE, peanut-
specific IgE; SNP, single-nucleotide polymorphism; SPT, skin prick test.
*Using the minor allele (T allele) as the effective allele and the major allele (G allele) as the reference allele.
wUsing the minor allele (C allele) as the effective allele and the major allele (T allele) as the reference allele.
zThe GEE model was applied to estimate the effect size of each SNP (additive genetic model) on the risk of PA in PA cases versus 733 non-PA children, with adjustment for age and gender, and controlling
for within-family relationships.
yThe MQLS test was applied to estimate the P-value by comparing PA cases, 144 non-allergic, non-sensitized normal controls and 1,737 controls of uncertain phenotype.
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Figure 4 | DMPs associated with rs7192, rs9275596 and with PA, as well as DMPs that mediate genetic risk in PA. (a) Diagram showing associations
between genotype (rs7192 (blue circle) and rs9275596 (green circle)) and DMPs, and between the genotype-dependent DMPs and PA. The DMPs are
denoted by empty circles. Dashed blue (for rs7192) and green (for rs9275596) lines represent significant associations between genotypes and DMPs at
Po5 10 8 based on linear regression models (N¼ 218). In between the DMPs and gene tracks are purple bars that represent the genotype-dependent
DMPs that are associated with PA based on linear regression models in 73 PA cases and 67 non-PA controls (DMPs as the outcomes). The two DMPs
marked with purple triangles are DMP cg15982117 in the HLA-DRB1 gene and DMP cg18024368 in the HLA-DQB1 gene that may mediate genetic risk in PA,
as determined by the CIT. (b) DMP cg18024368 in the HLA-DQB1 gene that may mediate the association between the rs7192 genotype and PA risk in 73
PA cases and 67 non-PA controls. The left panel shows the association between the methylation level at DMP cg18024368 and the rs7192 genotype. The
middle panel depicts the association between the methylation level at DMP cg18024368 and PA. The blue bars in the left and middle panels represent
median methylation levels. The right panel shows the effect size of the observed rs7192–PA associations (represented by ORs based on the logistic
regression model) before and after adjusting for the methylation level at DMP cg18024368 (M), as well as adjusting for both the methylation level at DMP
cg18024368 (M) and at DMP cg15982117 (M2). Error bars represent the 95% CIs of the estimated ORs.
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for DMP cg18024368, suggesting that this DMP acts as a
mediator (PCIT¼0.002, Bonferroni adjusted PCIT¼ 0.016;
Table 4). Similar associations were found for DMP cg15982117
in the HLA-DRB1 gene (Table 4 and Supplementary Fig. 3), and
the estimated OR for the rs7192–PA association was close to 1.0
after adjusting for both DMPs (cg18024368 and cg15982117;
Fig. 4b, right panel).
Additional supporting analyses. To maximize the study power,
we performed genome-wide meta-analysis for PA across the
discovery and the replication samples of European ancestry (total
N¼ 2,328) using 5,693,167 imputed and genotyped autosomal
SNPs (see Methods). Imputed SNP rs33980016 in the HLA-DQB1
gene remained the top SNP for PA (Pmeta¼ 2.9 10 12), fol-
lowed by imputed SNP rs9273841 (Pmeta¼ 5.2 10 11) and
genotyped SNP rs9275596 (Pmeta¼ 6.3 10 11; Supplementary
Table 2 and Supplementary Fig. 2). SNP rs7192 was also sig-
nificantly associated with PA (Pmeta¼ 2.8 10 9) (Table 2).
These findings further support that the 6p21.32 region is sig-
nificantly associated with the risk of PA. No additional sig-
nificant/suggestive signals outside of the 6p21.32 region were
identified.
Given the unique LD pattern in the HLA region, we imputed
the classical HLA alleles in individuals of European ancestry using
the HLA*IMP framework41. In the discovery stage, 50 HLA
alleles in the major histocompatibility complex (MHC) class II
region with a frequency of 0.02 or above were analysed
for possible association with PA. HLA-DQA1*0102 was the
only risk allele significantly associated with PA (P¼ 4.5 10 8).
This was confirmed in the replication sample of European
ancestry (P¼ 0.025) and in meta-analysis (Pmeta¼ 5.0 10 9;
Supplementary Table 5). To compare the relative effects of
different HLA variants in association with PA, we imputed
classical two-digit and four-digit HLA alleles, and amino
acid (AA) polymorphisms in the MHC class II region, using
the SNP2HLA framework42. The four-digit classical HLA
alleles imputed by SNP2HLA were concordant with those
imputed by HLA*IMP and HLA-DQA1*0102 continued to be
significantly associated with PA. A two-digit classical HLA
allele, HLA-DQB1*06, was also significantly associated with
PA in both the discovery and the replication samples of
European ancestry (Supplementary Table 5). Similar
associations were found for these two genes when AA
polymorphisms were analysed instead (Supplementary Table 5).
Among all of the classical HLA alleles and AA polymorphisms
tested, the AA polymorphism at position 71 in the HLA-DRB1
gene showed the top association signal with PA in both the
discovery stage (P¼ 2.3 10 10) and in the meta-analysis
(Pmeta¼ 9.8 10 11), in which the presence of Arg at position
71 was associated with a decreased risk of PA (Supplementary
Table 5). A similar association trend was also found for this
polymorphism in the replication sample, although it was
statistically insignificant (P¼ 0.189). All of these associations
were greatly reduced by conditioning on rs9275596 or rs7192
(P40.008), suggesting that these identified classical HLA alleles
and/or AA polymorphisms may not be independent of the two
validated PA-associated SNPs reported here.
By querying existing expression quantitative trait loci (eQTL)
databases for populations of European ancestry, we found both
rs7192 and rs9275596 were significantly associated with expres-
sion levels of the HLA-DRA, HLA-DRB5, HLA-DRB1, HLA-
DQA1, HLA-DQB1 and HLA-DQA2 genes in subcutaneous/
omental adipose43, liver43 and lymphoblastoid cell lines (http://
regulome.stanford.edu; Supplementary Table 6)44–46. We then
explored the most significant cis-eQTLs for these six genes in
subcutaneous/omental adipose and liver cell lines, separately
(Supplementary Table 7). SNP rs7192 was in almost complete LD
(r2¼ 0.99) with rs3763327 (an intergenic SNP between the HLA-
DRA and HLA-DQB9 genes), the most significant cis-eQTL of the
HLA-DRA gene in the liver, and the association between rs7192
and HLA-DRA1 gene expression (P¼ 1.9 10 16) was
comparable to that of rs3763327(P¼ 1.8 10 16). These
results indicate that rs7192 is a potential cis-QTL of the HLA-
DQA1 gene in the liver (Supplementary Table 7). In contrast,
rs9275596 was in low-to-moderate LD (r2o0.61) with the most
significant eQTL for each gene–tissue combination.
Discussion
There is growing evidence that genetic factors may play a role in
FA; however, there is a particular lack of knowledge regarding the
genetic and epigenetic underpinnings of FA as a whole and also
its subtypes47. We conducted the first GWAS study of well-
defined FA, including specific subtypes (peanut, milk and egg) in
US children, a particularly important age group given that FA
most commonly develops in early childhood. In addition, this is
the first study to demonstrate the key role of differential DNAm
in mediating identified genetic risk factors for PA. Specifically, we
identified and replicated genetic variants in the HLA-DR and -DQ
Table 4 | Differentially methylated positions that mediate genetic risk in PA.
DMPw DMP annotation DMP–rs7192
associationsy
DMP–rs9275596
associationsy
DMP–PA
associationsz
P for the CIT testww
Position Nearest gene Locationz b|| P b|| P b# P** rs7192 rs9275596
cg17039645 32294503 C6orf10 Gene body 0.04 4.4 10 14 0.03 7.1 10 9 0.05 5.4 10 7 0.162 0.155
cg18111114 32498493 HLA-DRB5 TSS1500 0.10 5.5 10 25 0.09 3.2 10 22 0.10 1.6 10 5 0.098 0.037
cg15982117 32552106 HLA-DRB1 Gene body 0.09 8.9 10 10 0.09 3.1 10 10 0.15 3.8 10 7 0.002* 0.002*
cg18024368 32632848 HLA-DQB1 Gene body 0.04 2.7 10 10 0.05 3.1 10 13 0.06 2.4 10 6 0.002* 0.003*
CIT, causal inference tests; DMP, differentially methylated position; GWAS, genome-wide association study; PA, peanut allergy; SNP, single-nucleotide polymorphism; TSS, transcription start site.
*Po0.05 after Bonferroni correction for four tested DMPs and two SNPs (cutoff: Po0.006 for 8 tests).
wRepresented by Infinium HumanMethylation450 BeadChip probe name. For each gene, only the top DMP that was genome-wide significantly associated with both SNPs (Po5 108) and that had the
strongest association with risk of PA is shown.
zLocation of the methylation CpG site, in relation to the nearest gene.
yLinear regression models were applied to test SNP–DMP associations in a subset of 218 children of European ancestry with available GWAS data and DNA methylation data, with adjustment of age,
gender and the estimated cell composition.
||Adjusted methylation difference with an increase of one copy of the risk allele (T allele for rs7192; or C allele for rs9275596).
zLinear regression models were applied to test the DMP-PA associations in 73 PA cases and 67 controls of European ancestry, with adjustment of age, gender and the estimated cell composition.
#Adjusted methylation difference between 73 PA cases and 67 controls of European ancestry.
**Po0.00069 (¼0.05/72) represents the significance level after Bonferroni correction.
wwCausal inference tests (CIT) were performed for the 4 DMPs in 73 peanut allergic cases and 67 controls of European ancestry using the modified version for binary outcomes.
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gene region that were significantly associated with PA in children
of European ancestry, tagged by rs7192 (a non-synonymous SNP
of the HLA-DRA gene) and/or rs9275596 (intergenic between the
HLA-DQB1 and HLA-DQA2 genes). Both rs7192 and rs9275596
significantly affect DNAm in several nearby genes. DNAm in the
HLA-DRB1 and HLA-DQB1 genes, in turn, mediate the detected
SNP–PA associations. Taken together with a PAR of 19%–21%,
this GWAS indicates the possibility that the HLA-DR and -DQ
gene region likely poses the single greatest genetic risk for PA.
The role of HLA variants in PA has been examined by previous
candidate gene studies via direct assessment of HLA classical
alleles12–14,16–18, but the results were inconclusive, partly due to
relatively small sample sizes and inadequate control of potential
population stratification. This GWAS provides convincing
evidence that the HLA-DR and -DQ gene region, as tagged by
rs7192 or rs9275596, harbours significant genetic risk for PA in
subjects of European ancestry. These two SNPs may represent
one single risk factor, as the association between rs9275596 and
PA was not independent of rs7192. To maximize the study power,
we conducted a meta-GWAS across the discovery and the
replication samples on a combined set of genotyped and imputed
SNPs, which further supports this HLA-DR and -DQ gene region
as a single significant region for PA.
Our findings are biologically plausible. The HLA-DR and -DQ
molecules, which are expressed in a range of cells, including B
cells, activated T cells and the monocyte/macrophage lineage, are
known to play a critical role in the development of allergy48.
These molecules present antigen-derived peptides, mostly of
exogenous origin, to CD4þ helper T cells. Antigen presentation
by HLA molecules is a defining step in the development of
antigen-specific immune responses. These molecules have
extensive molecular polymorphisms confined to the peptide-
binding groove. These polymorphisms may determine which
antigen-derived peptides are bound and presented to T cells via
T-cell receptors, and may account for allergen-specific
sensitivities. The top PA-associated AA polymorphism, at
position 71 in the HLA-DRB1 gene (imputed by SNP2HLA), is
one such polymorphism located in the peptide-binding groove
and may partly account for the identified associations. Previous
studies have shown that this AA position, together with positions
13, 70 and 74, play important roles in the binding-specificity
profile of pocket 4, which is one of the most important pockets
for antigen interaction and presentation by the HLA-DR
molecule49. Another possible explanation for our findings is
that rs7192, a missense SNP in the HLA-DRA gene, may directly
affect HLA-DRA protein function and/or expression and thus
affect binding of HLA molecules with peanut allergens. This SNP
was significantly associated with HLA-DRA gene expression in
multiple tissues including adipose, liver and lymphoblastoid cell
lines, which probably represent associations in antigen presenting
cells throughout the body. In the liver, rs7192 may be an actual
eQTL of the HLA-DRA gene, because (1) it is in almost complete
LD with the top cis-eQTL (rs3763327) of the HLA-DRA gene
(r2¼ 0.99) and (2) it induces a Leu242Val change in the HLA-
DRA gene, while rs3763327 is an intergenic SNP between the
HLA-DRA and HLA-DQB9 genes with unknown functionality.
The liver has been demonstrated to play a critical role in oral
tolerance induction50. It would be of great interest to further
examine these associations in additional tissues such as the
intestinal mucosa and skin, which are likely to be critical to the
pathogenesis of PA. We still cannot exclude the possibility that
other untyped variants that are in high LD with rs7192 or
rs9275596 could be the causal SNP(s). Although the imputed
SNP, rs33980016, showed the strongest association with PA, our
conditional analyses indicate that this top SNP signal is not
distinguishable from the signals at rs9275596 or rs7192 with our
current data. Our data provide strong evidence that the 6p21.32
region poses significant risk for PA. However, targeted
sequencing in this region is needed to more precisely identify
and validate the causal variant(s) for PA.
There is growing evidence that genotype may control DNAm
levels30,31. DNAm, which regulates gene expression, might
influence disease development in a manner complementary to
direct mutation of the DNA sequence itself. A recent small
epigenome-wide association study identified DMPs in the
HLA-DQB1 gene for IgE-mediated FA51. Genetic and epigenetic
modification may also interact biologically52. We showed that
both rs7192 and rs9275596 were methylation quantitative loci for
the HLA-DRB1 and HLA-DQB1 genes, and that there are
significant causal relationships among the genotypes, DNAm
and the risk of PA. This indicates that DNAm may regulate the
expression levels of these genes and, subsequently, may partly
mediate the genetic risk of PA. A similar linkage was observed for
rheumatoid arthritis in a recent study, although the involved
SNPs and DMPs in the HLA region were not the same as those
identified in our study32. Given the genetic associations with the
HLA region and disease pathogenesis that have already been
linked to specific HLA protein epitopes, the methylation
mediation observed here implies an additional complementary
mechanism by which the HLA variants may influence PA. This
study represents the first step in understanding the role of DNAm
mediation effects on PA. Our findings provide clues and
underscore the need for additional functional studies, including
follow-up data on independent PA subjects in a clinical setting, to
show how genotype-dependent DNAm could regulate the
expression of key genes, and how these expression patterns
may correlate with clinical outcomes. Longitudinal cohort studies
on DNAm at multiple time points are also needed to assess
dynamic changes in DNAm and its temporal relationship with
the risk of PA.
We showed that the identified SNP–PA associations were not
observed for milk allergy, egg allergy or other allergic phenotypes
(including allergic sensitization, self-reported physician-diag-
nosed asthma, eczema and allergic rhinitis; Supplementary
Table 3), raising the possibility that PA may be under distinct
genetic control. However, this study is underpowered on a
genome-wide level, both for ‘any FA’ and for its subtypes. The
finding of an association with PA should be interpreted cautiously
in the context of limited study power. The lack of association
between the two PA-associated SNPs, and other FA and/or other
allergic phenotypes may be due to limited sample size and limited
study power, hence requiring further studies in a larger sample.
Our study is also limited in the following aspects. As is the case
in most GWAS studies, we examined the genetic associations for
common variants. Substantially larger sample sizes will be
required to identify rare variants or common variants with small
effects. We replicated our GWAS results in an independent set of
samples from the same Chicago Food Allergy Study. Our findings
could be further strengthened by additional replications in other
independent populations. The significant associations that we
identified between rs7192 and rs9275596 and PA were not
present in the participants of non-European ancestry; however,
we cannot firmly conclude that these effects are specific to
population of European ancestry due to a limited sample size of
non-Europeans.
Batch effect is one of the major problems often encountered in
epigenetic studies53. We used ComBat54 transformation of
methylation data to minimize potential confounding by batch
effects. After transformation, the average DNAm level of the
reported DMPs in PA cases or controls did not vary significantly
across plates. Another issue linked to epigenetic studies is related
to tissue- and cell-specific characteristics. FA is a systemic
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7304
8 NATURE COMMUNICATIONS | 6:6304 | DOI: 10.1038/ncomms7304 |www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
condition for which the study of methylation patterns in blood
may be feasible, although cell heterogeneity in blood may act as a
potential confounder55,56 due to the cell-specific pattern of
DNAm57. Accordingly, we adjusted for estimated cell
composition using the ‘limma’ package58 in all epigenetic
association tests. However, we could not exclude the possibility
of some residual confounding. The identified DNAm mediation
effects will require replication and verification in future studies.
In summary, this GWAS of FA revealed one significant peak at
6p21.32 for PA, and the finding appears to be consistent based on
analyses of genotyped SNPs, imputed SNPs, imputed classical
HLA alleles and AA polymorphisms, and a meta-GWAS across
the discovery and replication samples. Specifically, this study
identified PA-specific susceptibility loci in the HLA-DQ and -DR
region at 6p21.32, tagged by rs7192 and rs9275596. Both SNPs
were associated with differential DNAm levels at multiple CpG
sites and differential DNAm of the HLA-DQB1 and HLA-DRB1
genes partially mediated the identified SNP–PA association.
Taken together with a PAR of 19%–21%, this study indicates the
possibility that the HLA-DR and -DQ gene region likely poses the
single greatest genetic risk for PA. Findings from this study
warrant additional replication, validation and functional studies,
which will have the potential to improve our understanding of the
genetic factors and epigenetic mechanism underlying the risk of
PA, and may inform future development of new strategies for the
prediction, prevention and treatment of PA.
Methods
The Chicago Food Allergy Study. Both the discovery and replication samples
were enrolled as part of the Chicago Food Allergy Study under a standard study
protocol. All participants were recruited from the Chicago area from August 2005
to June 2011. Eligible families were those having either one or both parents with at
least one biological child (aged 0–21 years) with or without FA, willing to parti-
cipate in the study. Eligible FA case or control children (aged 0–21 years) were
those with or without FA. For each family or participant, the following procedures
were completed: (1) questionnaire interview by trained research staff to obtain
information on each family member’s home environment, diet, lifestyle, history of
FA and other allergic diseases; (2) clinical evaluation by nurse or trained research
staff to obtain height, weight, waist and hip circumference, blood pressure mea-
surement and lung function test; (3) allergy SPT; and (4) collection of venous blood
samples for food specific IgE (sIgE) measurement, DNA extraction and subsequent
laboratory assays. Detailed information on SPT and sIgE measurement is given in
the Supplementary Methods. For each child, we also collected a detailed history of
clinical allergic reaction on ingestion of specific foods. The study protocol was
approved by the Institutional Review Board of Ann and Robert H. Lurie Children’s
Hospital of Chicago and the Institutional Review Board of Johns Hopkins
Bloomberg School of Public Health. Written informed consents were obtained
from all participants or their legal guardian (for children aged o18 years).
Study sample included in the current GWAS of FA. In the discovery stage, we
primarily used samples from nuclear families. A total of 2,759 subjects (853
families) were included. Among these families, 780 families (n¼ 2,678) were
included based on the following criteria: (1) at least one child had a convincing
history of clinical allergic reaction on ingestion of specific foods and (2) two or
more additional family members (parents/siblings) had archived DNA samples.
Another 81 children from 73 families without parental genotyping data were also
included (29 FA cases and 52 controls).
In the replication stage, we aimed to replicate the identified genetic associations
with PA. We included 216 case–control samples (88 PA cases and 128 controls)
from the Chicago Food Allergy Study, all independent of the discovery sample.
Definitions of phenotypes of interest. The main phenotypes of interest included
‘any FA’ and the three most common types of FA: PA, egg allergy and milk allergy.
As we reported previously, we adopted stringent clinical criteria to define a specific
type of FA35: (1) a convincing history of clinical allergic reaction on ingestion of
specific foods35 and (2) evidence of sensitization to the same food, defined as
having a detectable sIgE (Z0.10 kU l 1; detection limit of the instrument was
o0.10 kU l 1) and/or a positive SPT to this specified food. A positive SPT for a
specific allergen was defined based on criteria as follows: (1) the MWD for the
negative control was o3mm, the positive control was Z3mm and the difference
of positive minus negative control wasZ3mm; and (2) MWD wasZ3mm for the
specified allergen. Accordingly, we defined allergy to nine common foods (peanut,
egg white, cow’s milk, soy, wheat, walnut, fish, shellfish and sesame seed) and ‘any
FA’ if a child was allergic to any of these foods. Normal controls were defined if a
child had neither clinical allergic reaction nor evidence of sensitization to any of the
nine foods. All parents were defined as having uncertain FA phenotypes, as data on
history of clinical allergic reaction subsequent to ingestion of specific foods were
unavailable. We also performed sensitivity tests on FA definitions using other
cutoffs for food-specific IgE and SPT, for example, food-specific IgEZ0.35 kU l 1,
SPT MWDZ5mm (ref. 36) or either food-specific IgE or SPT MWDZ95% PPV.
Genotyping and quality control steps in the discovery GWAS. Genomic DNA
was isolated from EDTA-treated peripheral white blood cells. The concentration
and purity was determined using a Quant-iT Broad-range dsDNA Assay Kit on a
SpectraMax M2 micro-plate reader. Genotyping was performed using the Illumina
HumanOmni1-Quad BeadChip in the Genome Technology Access Center,
Washington University in St Louis, MO, according to specifications listed in
Illumina’s protocol (Illumina, Inc.). Among 2,759 genotyped samples, 12 failed to
yield high-quality genotyping calls (Supplementary Methods), resulting in an
overall genotyping success rate of 99.6%.
Genotypes for 2,747 subjects were exported, with a total of 1,011,859 SNPs. We
performed rigorous quality-control steps as suggested by Laurie et al.59, using the
R/bioconductor package ‘GWASTools’60. Briefly, we examined the following
parameters: (1) missing call rate per SNP, per chromosome and per sample; (2) the
reproducibility rate among the 100 duplicated samples; (3) duplicate discordance
estimates for each SNP to infer SNP quality; 4) genotyping batch effects: measured
by comparing the difference in allelic frequencies between each plate and a pool of
the other plates, and by comparing variation in log10 of the autosomal missing call
rate in each plate (no significant batch effects were detected); (5) gender identity:
based on X chromosome heterozygosity and the means of the intensities of SNP
probes on the X and Y chromosome; (6) autosomal heterozygosity; (7) Hardy–
Weinberg equilibrium (HWE) test: performed among self-reported Caucasian
parents or a sibling without FA if no parent was available. Sex-specific HWE tests
were also performed; (8) Mendelian error check of 650 families with both parents
available; and (9) pair-wise sample relatedness: pair-wise kinship estimates between
every subject were computed using PLINK61.
We filtered 45,100 monomorphic SNPs and 14,948 SNPs with a 45% missing
genotyping rate. A total of 595 SNPs with duplicate discordance estimates42% in
98 pairs of duplicates and 1,784 SNPs that deviated from the HWE test
(Po1 10 6) were also filtered. Mendelian error checks filtered 2,145 SNPs with
Mendelian errors in Z10 families (41.5% families). Some SNPs were filtered
under more than one criterion. We also removed 162,283 SNPs with minor allele
frequency (MAF) o2% and 2,086 SNPs on the Y chromosome or on
mitochondrial chromosomes. Finally, a total of 772,141 autosomal SNPs and
17,536 SNPs on the X chromosome were used in the downstream analyses.
We removed one subject with a missing genotyping call rate 45%, 12 subjects
with gender discrepancies and 6 subjects with Mendelian errors in 45,000 SNPs.
Pair-wise relatedness was checked for each pair of subjects by plotting the
proportion of loci where the pair shared one allele identical by descent versus the
proportion of loci where the pair shared zero allele identical by descent. A total of
34 subjects for whom the degree of relatedness was inconsistent with self-reported
relationship were then removed. In total, 2,694 subjects were available for
downstream data analyses.
Genetic ancestry was carefully computed by PCA using Eigenstrat37 and all
European, American, African and Asian individuals in the 1000 Genomes Project
were used as a reference (phase I, release_v3.20101123), as detailed in
Supplementary Methods.
Statistical analyses in the discovery GWAS. To leverage the family-based data
with a small number of case–control samples, the MQLS test (for autosomal
markers)33 and its’ extension, the XM test34 (for X-linked markers) were applied to
explore genetic associations for each phenotype of interest using MQLS-XM
(http://www.stat.uchicago.edu/Bmcpeek/software/MQLS_XM/download.html), a
programme for dichotomous outcomes. The MQLS can maximally use information
available in a complex family structure by the following: (1) distinguishing between
unaffected controls and controls of uncertain phenotypes (that is, individuals with
unmeasured phenotypes), and incorporating both into the analyses; and (2)
incorporating phenotype data for relatives with missing genotype data at each
marker tested33. MQLS is a retrospective score test that treats the genotype data on
sample individuals as random and the available phenotype information as fixed in
the analysis, thus allowing for valid association testing in the presence of phenotype
misspecification, and hence the method provides high power at the appropriate
type I error rate33. Before the MQLS analysis, using PA as an example, the
phenotype of interest was coded as follows: (1) PA-affected cases, (2) non-allergic
non-sensitized normal controls and (3) controls of uncertain phenotypes
(including children who did not meet the PA case or normal control definition, and
all genotyped parents). We also performed a sensitivity test and found that the
results were not significantly altered by removing children who did not meet the
PA case or normal control definition from the analysis. The MQLS test was
performed under an additive genetic model, with a specified prevalence of 5% for
any FA or 1% for PA, milk allergy and egg allergy, separately, in the Europeans. We
also repeated the analyses, while specifying a higher prevalence (10% for any FA, or
5% for PA, milk allergy and egg allergy, separately) and obtained very similar
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results. To perform MQLS analyses by conditioning on one of the top SNPs, we
first calculated the residual using logit(Y¼ 1)¼b0þ bG*G for subjects with non-
missing phenotypes, where Y is the disease status and G is the genotype of the
selected top SNP. The residual was set to 0 for subjects with missing phenotype.
Similarly, to perform MQLS analyses in 497 non-European subjects adjusting for
ancestry, the residual PA status for subjects with non-missing phenotypes was
calculated using the first three PCs from the GWAS genotyping data as covariates
and the residual for subjects with missing phenotypes was set to 0. The calculated
residual was then used as the outcome to perform MQLS analyses using the QM-
QXM programme, an approach that is an extension of the MQLS test to
quantitative traits (http://faculty.washington.edu/tathornt/software/QM_QXM/).
As the MQLS is a score test and does not estimate effect size, the reported OR and
95% CIs were estimated using GEE models, with adjustment for age and gender in
subjects of European ancestry. The first three PCs were also adjusted in the analyses
for non-European subjects.
Genotyping and data analyses in the replication sample. The replication
sample consisted of 88 PA cases and 128 normal controls from the same Chicago
Food Allergy Study. SNPs rs7192 and rs9275596, which were suggestively or sig-
nificantly associated with PA in the discovery GWAS (Po1 10 7), were selected
for replication. As we needed to impute population ancestry using a similar strategy
as was used for the discovery sample, and impute classical HLA alleles and AA
polymorphisms based on a relatively dense SNP set, the Human OmniEx-
pressExome BeadChip was selected for genotyping. DNA samples were prepared
using the same lab procedures as for the discovery sample, and cases and controls
were distributed evenly in each plate. Genotyping was performed according to
specifications listed in Illumina’s protocol (Illumina, Inc.) at the Genomics Core
Facility of the Department of Genetics and Genomic Sciences, Icahn School of
Medicine at Mount Sinai. Similar quality-control steps were applied to the repli-
cation sample. Two subjects with gender inconsistencies and one subject from a
monozygotic twin pair were removed from the subsequent data analysis. GEE
models, adjusting for age and gender, were performed to test the association
between each SNP and PA under an additive genetic model, in samples with
European ancestry. When analyses were performed in samples of non-European
ancestry, the first three PCs from the genome-wide SNP genotyping data were also
included as covariates to adjust for potential population stratification.
SNP imputation. In the discovery sample, we performed phasing using SHA-
PEIT38 and imputation using IMPUTE2 (ref. 39) with all individuals in the 1000
Genomes Project as a reference panel. As MQLS does not support analyses using
posterior probabilities, we computed best-guess genotypes, using a probability
threshold of 0.95, as recently described in the literature62. We applied several post-
imputation quality-control metrics including removal of SNPs with an IMPUTE2
info score o0.8, with a missing call rate 40.05, or with a MAF o0.02. A total of
6,459,842 genotyped or imputed SNPs were then analysed for their associations
with any FA and three specific types of FA, respectively, using the MQLS test.
Meta-GWAS. SNP imputation was also performed for the replication sample of
European ancestry, leading to a combined set of 6,174,271 genotyped or imputed
SNPs. We performed the association tests for PA in the replication sample using
the GEE model (in a case–control setting), adjusting for age and gender, similar to
what was done for genotyped SNPs rs7192 and rs9275596. To maximize power, we
performed meta-analysis based on the Stouffer’s weighted z-score method to
combine the association results for PA from the discovery and the replication
samples. Our GEE analyses in the replication sample did not include SNPs on the X
chromosome (N¼ 139,697) because of the small replication sample size and need
to perform gender-specific GEE analyses (57 females and 74 males), and thus the
meta-analysis was limited to 5,693,167 autosomal SNPs that overlapped in both
sample sets.
Imputation of HLA alleles and AA polymorphisms. We used the HLA*IMP41
programme to impute classical HLA alleles from SNP genotyping data via reference
to a training data set of over 2,500 samples of European ancestry with dense SNP
data and classical HLA allele types. This framework is reported to have high
imputation accuracy (92%–98% of imputations agree with lab-derived HLA
types)41. We also applied the SNP2HLA framework to impute AA polymorphisms
as well as classical HLA alleles, with genotype data from the Major
Histocompatibility Complex Working Group of the Type I Diabetes Genetics
Consortium as a reference panel42. The imputation was performed for subjects of
European ancestry in the MHC class II gene region. We used best-guess genotypes
for analyses, as MQLS does not support analysis using posterior probabilities. After
applying several quality-control filters to the imputed data (that is, removal of
imputed variants with call rate o95% and/or MAF o0.02), 50 four-digit HLA
alleles from the HLA*IMP programme, 27 two-digit HLA alleles, 41 four-digit
alleles and 165 AA polymorphisms from the SNP2HLA programme were analysed
for their associations with PA, using the MQLS test in the discovery sample and
using the GEE model in the replication sample, as described above. Multiallelic AA
polymorphisms were analysed for associations with PA after converting K-alleles to
K-bialleles.
DNA methylation measurement and quality-control steps. A total of 218
unrelated children of European ancestry in the discovery (N¼ 199) or replication
(N¼ 19) samples had genome-wide DNAm data measured in genomic DNA
isolated from EDTA-treated peripheral white blood cells. DNAm was measured
using Infinium HumanMethylation450 BeadChips (including 4485,000 CpG
sites), according to the manufacturer’s instructions at the Center for Genetic
Medicine, Northwestern University Feinberg School of Medicine. Several quality-
control steps were performed with the ‘minfi’ framework63, as detailed in the
Supplementary Methods. Both b-and M-values (representing methylation ratios)
were computed for downstream analyses. M-values are reported as superior to b-
values for identification of differential methylation64.
To account for potential batch effects, b- and M-values were ComBat-
transformed using the ‘sva’ package65, with chip number as the surrogate for
batches. The ComBat-transformed b- and M-values at each CpG site were applied
to explore associations between DNAm, genotypes and PA.
Cell heterogeneity in blood may act as a potential confounder55,56 due to cell-
specific patterns of DNAm57. Thus, with estimateCellCounts() function included in
the ‘minfi’ package63, the distribution of six cell types (CD8T cells, CD4T cells, NK
cells, B cells, monocytes and granulocytes) was inferred for each sample based on
external reference DNAm signatures of the constituent cell type from Illumina
HumanMethylation450 BeadChips55,56. The estimated cell composition was
adjusted as a covariate in subsequent analyses.
Statistical analyses on DNA methylation mediation effects. To identify DMPs
associated with the two validated PA-associated SNPs, we applied the ‘limma’
package58 in R/bioconductor, to fit a linear regression model in 218 unrelated
children of European ancestry, with ComBat-transformed M-values at each CpG
site (N¼ 456,513) as a function of each SNP (under an additive genetic model),
adjusted for age, gender and estimated cell composition. Genome-wide significance
(Po5 10 8) cutoffs were applied. To report adjusted methylation differences in
each genotype, ComBat-transformed b-values were analysed instead of ComBat-
transformed M-values, which did not significantly change the results.
The identified genotype-dependent DMPs were tested for associations with PA,
by fitting a linear regression model with ComBat-transformed M-values as
outcomes, adjusting for the covariates mentioned above. These analyses were
conducted in 73 PA cases and 67 controls, while the remaining 78 children with
uncertain PA phenotypes were removed from these analyses. Bonferroni correction
was applied to adjust for multiple testing. To report adjusted methylation
differences in each group, ComBat-transformed b-values were analysed instead of
ComBat-transformed M-values, which did not significantly change the results.
The SNP–DMP–PA relationships were then assessed using the CIT
classification as methylation mediated, consequential, or independent40. We
focused on the top DMP from each gene that was significantly associated with both
SNPs and PA risk. Briefly, the CIT performs statistical tests for four conditions, all
of which must be met to conclude that methylation mediation is occurring: (i)
genotype and phenotype of interest (PA in the current study) are associated; (ii)
genotype is associated with DMP after adjusting for phenotype; (iii) DMP is
associated with phenotype after adjusting for genotype; and (iv) genotype is
independent of phenotype after adjusting for DMP. The CIT P-value is defined
using the intersection-union test framework as the maximum of the four-
component test P-values. As the CIT was originally designed for continuous
phenotypes, we applied a modified version based on logistic regression to examine
the causal relationship for each SNP–DMP–PA pair in this study, which has been
reported previously32.
Functional annotation using existing eQTL data sets. To identify potentially
causal gene(s) underlying the identified genetic associations with PA, we queried
existing eQTL databases in multiple tissues (including subcutaneous/omental adipose
tissue43, liver tissue43 and lymphocytes44–46 (http://regulome.stanford.edu)), to assess
whether the top PA-associated SNPs were eQTL SNPs. We surveyed both cis- and
trans-eQTLs of 10% false discovery rate and found that the two PA-associated SNPs
influence gene expression mainly in a cis manner, and that corresponding cis-eQTLs
were reported in the paper. For each gene whose expression level was significantly
associated with the two PA-associated SNPs, the most significant cis-eQTL in the
subcutaneous/omental adipose and liver tissues, separately, and its LD squared
correlation coefficient with the PA-associated SNPs were also reported.
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